R

Rocket Pharmaceuticals
D

RCKT

10.300
USD
0.10
(0.93%)
مغلق
حجم التداول
69,585
الربح لكل سهم
-3
العائد الربحي
-
P/E
-4
حجم السوق
1,095,271,976
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ASTC
    -0.06000
    (-0.91%)
    6.50000 USD
    BA
    BA
    2.140
    (1.27%)
    171.050 USD
    GD
    GD
    -2.16
    (-0.80%)
    266.71 USD
    K
    KTOS
    0.040
    (0.12%)
    33.650 USD
    LMT
    LMT
    3.43
    (0.70%)
    490.28 USD
    M
    MAXR
    0
    (0%)
    0 USD
    NOC
    NOC
    1.38
    (0.29%)
    482.38 USD
    RTX
    RTX
    0.590
    (0.49%)
    121.100 USD
    S
    SPCE
    -0.12500
    (-2.37%)
    5.15500 USD
    U
    U
    0.005
    (0.02%)
    21.760 USD
    المزيد
الأخبار
المقالات

العنوان: Rocket Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.